c-Kit signaling potentiates CAR T cell efficacy in solid tumors by CD28- and IL-2-independent co-stimulation
出版年份 2023 全文链接
标题
c-Kit signaling potentiates CAR T cell efficacy in solid tumors by CD28- and IL-2-independent co-stimulation
作者
关键词
-
出版物
Nature Cancer
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-06-20
DOI
10.1038/s43018-023-00573-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Regional CAR T cell therapy: An ignition key for systemic immunity in solid tumors
- (2022) Leonid Cherkassky et al. CANCER CELL
- Image-guided interventional radiological delivery of chimeric antigen receptor (CAR) T cells for pleural malignancies in a phase I/II clinical trial
- (2022) Mario Ghosn et al. LUNG CANCER
- BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells
- (2021) Hyungseok Seo et al. NATURE IMMUNOLOGY
- A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains
- (2021) Kathryn M. Cappell et al. Nature Reviews Clinical Oncology
- A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
- (2021) Prasad S Adusumilli et al. Cancer Discovery
- Detection of circulating immunosuppressive cytokines in malignant pleural mesothelioma patients for prognostic stratification
- (2021) Loredana Urso et al. CYTOKINE
- PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB “Super-Stimulation”
- (2021) Gaia Zuccolotto et al. Frontiers in Oncology
- Enhancing Chimeric Antigen Receptor T cell Efficacy in Solid Tumors
- (2020) Giovanni Fucá et al. CLINICAL CANCER RESEARCH
- Interleukin-23 engineering improves CAR T cell function in solid tumors
- (2020) Xingcong Ma et al. NATURE BIOTECHNOLOGY
- Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability
- (2020) Sonia Guedan et al. JOURNAL OF CLINICAL INVESTIGATION
- CD29 identifies IFN-γ–producing human CD8+T cells with an increased cytotoxic potential
- (2020) Benoît P. Nicolet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tuning the Antigen Density Requirement for CAR T-cell Activity
- (2020) Robbie G. Majzner et al. Cancer Discovery
- Excessive Costimulation Leads to Dysfunction of Adoptively Transferred T Cells
- (2020) Dinali Wijewarnasuriya et al. Cancer Immunology Research
- Optimization of T-cell Receptor–Modified T Cells for Cancer Therapy
- (2020) Dylan J. Drakes et al. Cancer Immunology Research
- Coexpression of IL7 and CCL21 Increases Efficacy of CAR-T Cells in Solid Tumors without Requiring Preconditioned Lymphodepletion
- (2020) Hong Luo et al. CLINICAL CANCER RESEARCH
- NR4A transcription factors limit CAR T cell function in solid tumours
- (2019) Joyce Chen et al. NATURE
- IFN-γ upregulates membranous and soluble PD-L1 in mesothelioma cells: potential implications for the clinical response to PD-1/PD-L1 blockade
- (2019) Maria Pia Pistillo et al. Cellular & Molecular Immunology
- Oncogenic KIT mutations induce STAT3-dependent autophagy to support cell proliferation in acute myeloid leukemia
- (2019) Clément Larrue et al. Oncogenesis
- An IL-4/21 Inverted Cytokine Receptor Improving CAR-T Cell Potency in Immunosuppressive Solid-Tumor Microenvironment
- (2019) Yi Wang et al. Frontiers in Immunology
- Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors
- (2019) Rachel Grosser et al. CANCER CELL
- Detection of TGF-β in pleural effusions for diagnosis and prognostic stratification of malignant pleural mesothelioma
- (2019) Paul Stockhammer et al. LUNG CANCER
- c-Jun overexpression in CAR T cells induces exhaustion resistance
- (2019) Rachel C. Lynn et al. NATURE
- Driving CARs on the uneven road of antigen heterogeneity in solid tumors
- (2018) Nan Chen et al. CURRENT OPINION IN IMMUNOLOGY
- Kit Mutations
- (2018) Lorenzo Falchi et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- A change in structural integrity of c-Kit mutant D816V causes constitutive signaling
- (2018) Pawan Kumar Raghav et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
- (2018) Joseph A. Fraietta et al. NATURE MEDICINE
- A novel chimeric antigen receptor containing a JAK–STAT signaling domain mediates superior antitumor effects
- (2018) Yuki Kagoya et al. NATURE MEDICINE
- Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors
- (2018) Paris Kosti et al. Frontiers in Immunology
- The Proto-oncogene c-Kit Inhibits Tumor Growth by Behaving as a Dependence Receptor
- (2018) Hong Wang et al. MOLECULAR CELL
- D816V mutation in the KIT gene activation loop has greater cell-proliferative and anti-apoptotic ability than N822K mutation in core-binding factor acute myeloid leukemia
- (2017) Ikuko Omori et al. EXPERIMENTAL HEMATOLOGY
- Therapeutic T cell engineering
- (2017) Michel Sadelain et al. NATURE
- Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity
- (2017) Purnima Bhat et al. Cell Death & Disease
- Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells
- (2017) Thomas Shum et al. Cancer Discovery
- Genome-wide Analysis of STAT3-Mediated Transcription during Early Human Th17 Cell Differentiation
- (2017) Subhash K. Tripathi et al. Cell Reports
- Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition
- (2016) Leonid Cherkassky et al. JOURNAL OF CLINICAL INVESTIGATION
- Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells
- (2016) Maryam Abbaspour Babaei et al. Drug Design Development and Therapy
- Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event
- (2015) M Jawhar et al. LEUKEMIA
- Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors
- (2015) A. Morello et al. Cancer Discovery
- Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15
- (2014) Y. Xu et al. BLOOD
- Kit and Scl regulation of hematopoietic stem cells
- (2014) Shanti Rojas-Sutterlin et al. CURRENT OPINION IN HEMATOLOGY
- Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity
- (2014) P. S. Adusumilli et al. Science Translational Medicine
- Systematic evaluation of spliced alignment programs for RNA-seq data
- (2013) Pär G Engström et al. NATURE METHODS
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Stem Cell Factor Receptor/c-Kit: From Basic Science to Clinical Implications
- (2012) Johan Lennartsson et al. PHYSIOLOGICAL REVIEWS
- A human memory T cell subset with stem cell–like properties
- (2011) Luca Gattinoni et al. NATURE MEDICINE
- Mechanisms of STAT Protein Activation by Oncogenic KIT Mutants in Neoplastic Mast Cells
- (2010) Amandine Chaix et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity
- (2009) Y. Feng et al. MOLECULAR CANCER THERAPEUTICS
- Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade
- (2008) N. Harir et al. BLOOD
- CD56brightnatural killer (NK) cells: an important NK cell subset
- (2008) Aurélie Poli et al. IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started